1-8 of 8
Luca Guerra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Prognostic Value of MTV Is Retained in New Proposed SUV 4 Threshold: An International Comparison of Follicular and Hodgkin Patient Survival

Stephane Chauvie, Luca Guerra, Federico Fallanca, Michele Gregianin, Annibale Versari, Rexhep Durmo, Fabrizio Bergesio, Adriano De Maggi, Enrica Bergalla, Alessandro Rambaldi, Simone Ferrero, Caterina Patti, Massimo Federico, Andrea Gallamini, Stefano Luminari
Journal: Blood
Blood (2024) 144 (Supplement 1): 6254.
https://doi.org/10.1182/blood-2024-206736
Published: 2024
Journal Articles

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Patrizia Mondello, Brianna J Negaard, Luca Arcaini, Joshua Tobin, Loic Chartier, Brian K. Link, Andrew L. Feldman, Dai Chihara, Carla Casulo, Anne Ségolène Cottereau, Luca Guerra, Joshua Olson, Jason T Romancik, Sara Haddadi, Harrison Black, Thomas Trevis, Eric Mou, Tsz Hung Tong, Kamilia Moalem, Anna M. Johnston, Paul J. Hampel, Jeffrey Johnson, Steinepreis Elizabeth, Pinguang Yang, Serena Kosciejew, Goodall Elizabeth, Kate Manos, Chan Y. Cheah, Ross Salvaris, Thomas M. Habermann, Peter Martin, Brad S. Kahl, Grzegorz S. Nowakowski, Georgina Hodges, Loretta Nastoupil, Dipti Talaulikar, Judith Trotman, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos, Richard Burack, Stefano Luminari, Franck Morschhauser, Stephen M. Ansell, Matthew J. Maurer
Journal: Blood
Blood (2024) 144 (Supplement 1): 3007.
https://doi.org/10.1182/blood-2024-202088
Published: 2024
Journal Articles

Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors: 5-Year Update of a Phase 2 Open Label Monocentric Study

Federica Colombo, Andrea Aroldi, Stefano Crippa, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2024) 144 (Supplement 1): 3117.
https://doi.org/10.1182/blood-2024-206041
Published: 2024
Journal Articles

PET Radiomics Discriminate Among Different Lymphoma Sub-Types

Stephane Chauvie, Lale Kostakoglu Shields, Luca Guerra, Annibale Versari, Federico Fallanca, Michele Gregianin, Fabrizio Bergesio, Enrica Bergalla, Adriano De Maggi, Denis Sahin, Rexhep Durmo, Umberto Vitolo, Massimo Federico, Andrea Gallamini, Alessandro Rambaldi, Stefano Luminari
Journal: Blood
Blood (2024) 144 (Supplement 1): 7505.
https://doi.org/10.1182/blood-2024-205170
Published: 2024
Journal Articles

Preliminary Results of Phase 2 Open Label Study of Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors

Alessia Ripamonti, Andrea Aroldi, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2023) 142 (Supplement 1): 4474.
https://doi.org/10.1182/blood-2023-186702
Published: 2023
Journal Articles

Total Metabolic Tumor Volume Is Confirmed As Independent Prognostic Factor in Treatment Naïve Follicular Lymphoma Patients and Can be Combined with FLIPI2 to Improve Prognostic Accuracy. a FOLL12 Substudy By the Fondazione Italiana Linfomi

Stefano Luminari, Luca Guerra, Carla Minoia, Stephane Chauvie, Antonella Anastasia, Federica Cavallo, Paolo Corradini, Sara Rattotti, Rexhep Durmo, Chiara Ghiggi, Jacopo Olivieri, Simone Ferrero, Gloria Margiotta Casaluci, Luca Nassi, Caterina Stelitano, Francesca Ricci, Vittorio Ruggero Zilioli, Antonio Pinto, Manuela Zanni, Bolis Silvia, Caterina Patti, Michele Merli, Annalisa Chiarenza, Gerardo Musuraca, Patrizia Tosi, Massimo Federico, Annibale Versari
Journal: Blood
Blood (2022) 140 (Supplement 1): 1313–1315.
https://doi.org/10.1182/blood-2022-166225
Published: 2022
Journal Articles

High Response Rates To Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients

Sara Redaelli, PhD, Francesca Farina, MD, Alessandra Stasia, MD, Monica Ceccon, PhD, Luca Mologni, PhD, Cristina Messa, MD, Luca Guerra, MD, Giovanni Giudici, MS, Elena Sala, MS, Lara Mussolin, PhD, Dries Deeren, MD, Michael H. King, MD, Michael Steurer, MD, Rainer Ordemann, MD, Amos Cohen, MD, Matthias Grube, MD, Lea Bernard, MD, Gianpaolo Chiriano, PhD, Rocco Piazza, MD, PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2013) 122 (21): 368.
https://doi.org/10.1182/blood.V122.21.368.368
Published: 2013
Journal Articles

Clinical Activity of Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients

Carlo B Gambacorti-Passerini, Ilaria Dilda, Giovanni Giudici, Alessandra Perego, Francesca Pavesi, Luca Guerra, Lorenza Borin, Ivana Casaroli, Marilena Fedele, Luisa Verga, Enrico Maria Pogliani
Journal: Blood
Blood (2010) 116 (21): 2877.
https://doi.org/10.1182/blood.V116.21.2877.2877
Published: 2010